
Opinion|Podcasts|February 5, 2025
Episode 2 Video: Identifying Patients with Intermediate Risk in NMIBC
Panelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Published BOND-003 data show durable responses with cretostimogene in NMIBC
2
Adanma Ayanambakkam, MD, discusses phase 1 data on darlifarnib plus cabozantinib in RCC
3
Darlifarnib plus cabozantinib shows encouraging antitumor activity in ccRCC
4
Cretostimogene Grenadenorepvec: Mechanism and Rationale
5


















